TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

被引:801
作者
Arnett, HA
Mason, J
Marino, M
Suzuki, K
Matsushima, GK
Ting, JPY [1 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med CB7295, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA
[3] Mem Sloan Kettering Canc Ctr, Ludwig Inst, New York, NY 10017 USA
[4] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1038/nn738
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.
引用
收藏
页码:1116 / 1122
页数:7
相关论文
共 48 条
  • [1] Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice - Models for multiple sclerosis with primary oligodendrogliopathy
    Akassoglou, K
    Bauer, J
    Kassiotis, G
    Pasparakis, M
    Lassmann, H
    Kollias, G
    Probert, L
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) : 801 - 813
  • [2] TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study
    Arnason, BGW
    Jacobs, G
    Hanlon, M
    Clay, BH
    Noronha, ABC
    Auty, A
    Davis, B
    Nath, A
    Bouchard, JP
    Belanger, C
    Gosselin, F
    Thibault, M
    Duquette, P
    Bourgoin, P
    DuBois, R
    Girard, M
    Ebers, GC
    Rice, GPA
    Vandervoort, MK
    Francis, GS
    Duncan, L
    Lapierre, Y
    Freedman, MS
    Christie, SN
    Rabinovitch, HE
    Patry, D
    Murphy, WF
    Peters, S
    McGuiness, SD
    Murray, TJ
    Bhan, V
    Maxner, CE
    Van Dorpe, R
    Oger, JJ
    Nelson, J
    Morrison, W
    Bogle, N
    Beall, S
    Vorobeychick, G
    Hiltbrunner, AV
    Bock, J
    Habil
    Lesslauer, W
    Li, DKB
    Paty, DW
    Zhao, GJ
    [J]. NEUROLOGY, 1999, 53 (03) : 457 - 465
  • [3] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [4] A CRUCIAL ROLE FOR NEUROTROPHIN-3 IN OLIGODENDROCYTE DEVELOPMENT
    BARRES, BA
    RAFF, MC
    GAESE, F
    BARTKE, I
    DECHANT, G
    BARDE, YA
    [J]. NATURE, 1994, 367 (6461) : 371 - 375
  • [5] Cytokine regulation of secondary lymphoid organ development
    Chaplin, DD
    Fu, YX
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) : 289 - 297
  • [6] Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability
    Coetzee, T
    Fujita, N
    Dupree, J
    Shi, R
    Blight, A
    Suzuki, K
    Suzuki, K
    Popko, B
    [J]. CELL, 1996, 86 (02) : 209 - 219
  • [7] Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor
    Croxford, JL
    Triantaphyllopoulos, KA
    Neve, RM
    Feldmann, M
    Chernajovsky, Y
    Baker, D
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (05) : 2776 - 2781
  • [8] Declercq W, 1998, J IMMUNOL, V161, P390
  • [9] Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia
    Dopp, JM
    MackenzieGraham, A
    Otero, GC
    Merrill, JE
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 75 (1-2) : 104 - 112
  • [10] Identification of autoantibodies associated with myelin damage in multiple sclerosis
    Genain, CP
    Cannella, B
    Hauser, SL
    Raine, CS
    [J]. NATURE MEDICINE, 1999, 5 (02) : 170 - 175